Trade Secrets – Strategic Considerations to Maximise Value for the Business

Jamie has over 20 years of experience advising on, protecting and enforcing clients’ valuable IP rights. His work has always been internationally-focused. Jamie has experience in all areas of IP law with a particular focus on dispute resolution. Whilst his primary focus is patent litigation, he has regularly advised clients in relation to confidential information and trade secrets on both contentious and non-contentious matters. He has provided IP advice in a wide variety of sectors including consumer products, telecoms, software, medical devices, aviation, automotive, oil & gas and advanced manufacturing.

Gemma handles a wide variety of software and telecommunications subject matter, with a particular emphasis on Artificial Intelligence and Machine Learning, drafting and prosecuting patent applications in the fields of Reinforcement Learning, Transfer Learning, and Distributed Learning, as well as applications of probabilistic graphical models, control theory and optimisation. Gemma assists clients in protecting innovation at the intersection of AI and multiple related disciplines, including telecommunciations, security and encryption technology.

Frances started her career as a Patent Examiner at the European Patent Office in Munich, where she spent 8 years working on examination and opposition of European cases and PCT examination, covering a variety of engineering and electronics fields. Frances then transferred to private practice in the UK.  At HLK, Frances has continued to work across a broad variety of fields, including mobile telecommunications, healthcare, medical and display technology, including user interfaces, simulation systems, data centres, design and implementation of neural networks (AI), and business and internet-based inventions.

Joseph specialises in obtaining and managing patent portfolios in the pharmaceutical and chemical industries. He is particularly experienced in EPO Oppositions and Appeals proceedings acting for clients in patent matters across a diverse range of technologies, and has also led patent proceedings in the Intellectual Property Enterprise Court and Court of Appeal. Joseph has developed substantial technical and professional expertise in the fields of new pharmaceutical chemical entities (including protein kinase inhibitors, ADCs and PROTACs), radiopharmaceuticals, oral protein formulations, dentistry, biocompatible materials, assay devices, glass technology and consumer product formulations.